Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
Are natural killer cells involved in multiple sclerosis etiology? Evidences from NKp46/NCR1 receptor modulation in an observational study.
Antioxidant properties of the triaminopyridine, flupirtine.
Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.
Dimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models.
Interferon β for secondary progressive multiple sclerosis: a systematic review.
Keystone Symposium: Multiple Sclerosis
Current and future immunotherapy targets in autoimmune neurology.
Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients.
Interferon beta for secondary progressive multiple sclerosis.
Paraoxonase 1 activity in multiple sclerosis patients during mitoxantrone therapy.
Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration.
Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report.
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.
Launch of a phase 3 clinical trial in the treatment of Alzheimer’s disease with masitinib
Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy.
UCSF Seminar: "Antibody Repertoire Sequencing"
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.
Santhera and NIH collaborate to evaluate Catena® in primary progressive multiple sclerosis
Monoclonal antibodies in MS: mechanisms of action.
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion.
Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol.
Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
Multiple Sclerosis.

Pages